0
29. 12. 2024.
Enhanced Survival Outcomes with FOLFIRINOX in Initial Metastatic Pancreatic Cancer: Single-Center Study
Enhanced Survival Outcomes with FOLFIRINOX in Initial Metastatic Pancreatic Cancer: Single-Center Study
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više